share_log
Reuters ·  Jan 27 12:00
GT Biopharma Announces First Patient Dosed in Phase 1 Trial of Gtb-3650, Second-Generation Trike for the Treatment of Hematologic Malignancies
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 371

Recommended

Write a comment